Stay updated on TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial
Sign up to get notified when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.

Latest updates to the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page
- Check6 days agoChange DetectedThe page footer/built version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3” for the site interface.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.1%

- Check20 days agoChange DetectedNo visible additions or deletions detected between the two screenshots; the page content appears unchanged.SummaryDifference0.1%

- Check27 days agoChange DetectedNo substantive content changes detected between the screenshots; the page content appears unchanged.SummaryDifference0.1%

- Check35 days agoChange DetectedSevere myoclonic epilepsy in infancy and Tuberous sclerosis syndrome were added, while Dravet syndrome and Tuberous sclerosis were removed. This appears to be terminology/keyword adjustments rather than a change to the study design or eligibility.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded revision label v3.5.0 and removed revision label v3.4.3.SummaryDifference0.1%

Stay in the know with updates to TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.